[Vasoactive intestinal polypeptide induced prolactin release is model dependent in free-moving rats]

Area of Science:

• Endocrinology
• Neuroendocrinology
• Physiology

Background:

• In vitro studies indicated that vasoactive intestinal polypeptide (VIP) stimulates pituitary prolactin (PRL) release, contingent on the animal's endocrine status.
• The in vivo effects of VIP on PRL secretion under varying physiological conditions remained largely undetermined.

Purpose of the Study:

• To investigate the in vivo effects of VIP on PRL secretion in rats.
• To determine if VIP's PRL-releasing activity is modulated by different physiological states, such as sex and lactation.

Main Methods:

• Rats were infused with VIP (5 µg/100 g body weight) via jugular vein cannulation.
• Blood samples were collected at intervals to measure VIP and PRL concentrations.
• Different physiological states were examined, including male, female (diestrus, proestrus), and lactating (suckled, separated) rats.

Main Results:

• VIP infusion rapidly increased VIP blood concentrations, peaking at 10 minutes and sustained for over 30 minutes.
• VIP significantly increased PRL concentrations in all tested animals (P < 0.05).
• The PRL response to VIP was highest in males and significantly lower in females and lactating rats, with notable differences between suckled and separated lactating mothers.

Conclusions:

• VIP administration in vivo stimulates PRL release.
• The magnitude of VIP-induced PRL secretion is significantly influenced by the animal's endocrine and neural status, including sex and reproductive condition.
• These findings highlight the context-dependent action of VIP in regulating prolactin secretion in vivo.